Zota Health Care

What Zota Health Care does

Zota Health Care Limited is an Indian pharmaceutical company founded in 2000 and headquartered in Surat, Gujarat. Listed on the National Stock Exchange of India (NSE: ZOTA), the company operates three integrated business segments: (1) manufacturing and marketing of pharmaceutical, nutraceutical, and ayurvedic products across 21 marketing divisions with a portfolio of 2,647+ domestic SKUs and 72+ international pharma products; (2) retail pharmacy chains including Davaindia (1,373+ stores offering generic medicines at 30-90% discounts versus branded alternatives) and the newer UGO Generic format; and (3) patented proprietary formulations including RTFIT, GMFIT, RTFIT-K27, and Zonuron-T. The company has applied for 19 patents and holds 7 granted patents (20-year terms) with PCT applications filed in 142 countries.

The revenue model combines distribution-led pharmaceutical marketing through 1,050+ direct distributors covering every district in India, a growing franchise-licensed retail pharmacy chain that contributes 74% of revenue at 98% year-on-year growth, and export operations to 22 countries from a 30,000 sq. ft. WHO-GMP certified manufacturing facility in Surat Special Economic Zone. Zota serves individual retail pharmacy consumers seeking affordable generic medicines, 1,050+ pharmaceutical distributors, and international buyers across India, Sri Lanka, Vietnam, and Nigeria. Recent strategic activity includes a ₹350 crore QIP completed December 2025 to fund DavaIndia expansion toward a stated target of 5,000+ stores by March 2029, subsidiary investments in Curexis Ventures and KMHP Ventures, and a pending 80% acquisition of Globotask IT Consultancy Services. The company is loss-making on a consolidated basis (net losses widened from ₹19 crore to ₹30 crore) as it pursues aggressive expansion.

Name

Zota Health Care

Legal name

Zota Health Care Limited

Website

https://zotahealthcare.com

Company type

Public

Founded year

2000

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Zota Health Care Limited is an Indian pharmaceutical company that develops, manufactures, and markets generic medicines, nutraceuticals, and patented formulations across 21 divisions, distributing through 1,050+ wholesalers, 1,373+ DavaIndia retail stores, and exports to 22 countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing and Retail Pharmacy

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmacies and Drug Retailers (456110), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834), Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industries

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), OTC Medicines & Consumer Health Products Distribution (CRAOAHAB), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

Keywords

• Pharmaceutical manufacturing
• Generic medicines
• Retail pharmacy
• Drug distribution
• Patented formulations

Headquarters

HQ city

Surat

HQ country

India

HQ region

Asia

Offices7 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Marketing: Domestic marketing of pharmaceutical products through 1,050+ direct distributors covering each district of India. Offers pharmaceutical, nutraceutical, and ayurvedic medicines across 21 divisions.
2. Export Business: Exporting pharmaceutical products to 22 countries through direct distributors. Manufacturing facility registered with WHO-GMP standards for international markets.
3. Retail Pharmacy Chain (DavaIndia): Company-owned and franchise-operated generic pharmacy retail stores offering medicines at 30-90% discounts. Contributes 74% of company revenue with 98% year-on-year revenue growth.
4. Patent Products: Revenue from patented formulations including GMFIT, RTFIT, RTFIT-K27, Zonuron-T and other novel oral compositions

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Zota Health Care Limited is a pharmaceutical drug development, manufacturing, and marketing company headquartered in Surat, India. The company manufactures and distributes pharmaceutical, nutraceutical, and ayurvedic products across 21 marketing divisions through 1,050+ direct distributors covering every district of India and exports to 22 countries. It also operates the DavaIndia generic pharmacy retail chain (company-owned and franchise-operated stores) selling medicines at 30-90% discounts to consumers, and develops patented formulations such as RTFIT, GMFIT, and Zonuron-T from its WHO-GMP certified manufacturing facility.

Product overview

Zota Health Care is a diversified pharmaceutical company operating three main business segments: (1) Manufacturing & Marketing of pharmaceutical, nutraceutical, and ayurvedic products through 21 marketing divisions with over 2,600 domestic products and 72+ international pharma products; (2) Retail pharmacy chains including Davaindia (company-owned and franchise generic pharmacy stores offering 30-90% discounts) and UGO Generic; and (3) Patented proprietary formulations including GMFIT, RTFIT, RTFIT-K27, and Zonuron-T. The company exports to 22 countries through direct distributors and maintains a manufacturing facility in Surat Special Economic Zone compliant with WHO-GMP standards.

Differentiator

Problem solved

Functional benefit

Brands

• GMFIT: Patented product - antioxidant composition
• RTFIT
• RTFIT-K27
• Zonuron-T
• DavaIndia
• Ugo Generic
• UGO Generic

Products and services

• DavaIndia Generic Pharmacy Retail Chain Generic retail pharmacy chain offering medicines at 30-90% discounts through company-owned and franchise-operated stores across India. Part of DavaIndia Health Mart Ltd subsidiary, providing affordable generic medicines to consumers. Currently operates 1,373 stores with plans to expand to 5,000+ stores by 2029.
• UGO Generic Pharmacy Retail Generic retail store format launched through subsidiary KMHP Ventures Limited to expand retail pharmacy presence across India with affordable generic medicines. Brand ambassador Akshay Kumar was signed in May 2026 to support brand expansion.
• RTFIT Unique combination of two amino acids for liver disorders, particularly alcoholic hepatitis, with a unique mode of action without complications due to its origin. One of the company's flagship patented nutraceutical products.
• RTFIT-K27 Patented pharmaceutical formulation developed by Zota Healthcare's R&D team for specific therapeutic applications.
• GMFIT Patented antioxidant composition product developed by Zota Healthcare as one of its proprietary branded formulations.
• Zonuron-T Patented pharmaceutical formulation by Zota Healthcare, one of the company's proprietary branded products for neurological applications.
• AZIVAR (Azithromycin Product Line) Antibiotic product line including AZIVAR Rediuse Suspension, AZIVAR-100 DT Tab, AZIVAR-250 Tab, AZIVAR-500 Tab, and combination products like AZIVAR-CX. Part of the domestic antibiotics portfolio distributed through 1,050+ distributors across India.
• CIFIVAR (Cefixime Product Line) Cephalosporin antibiotic product line including CIFIVAR-100 DT Tab, CIFIVAR-200 DT Tab, CIFIVAR-O Tab, and dry syrup formulations. Part of the domestic antibiotics portfolio.
• PANTOVAR (Pantoprazole Product Line) Proton pump inhibitor product line including PANTOVAR Tab, PANTOVAR-D, PANTOVAR-DSR, PANTOVAR-L, and PANTOVAR-O. Used for acid-related disorders and ulcer treatment. Part of the domestic pharmaceutical portfolio.
• Zomep ES (Esomeprazole) Bioequivalent international product for treatment of Gastro-Oesophageal Reflux Disease, Erosive Reflux Oesophagitis, and Zollinger Ellison Syndrome. Available in 20mg and 40mg strengths for export markets.
• Coxzota (Etoricoxib) Bioequivalent NSAID product for pain and inflammation treatment associated with acute gouty arthritis, Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis. Available in 60mg, 90mg, and 120mg strengths for export markets.
• B12 Splash Oral Spray International health supplement product containing Vitamin B12 1500 mcg, L-Taurine 100mg, and Folic Acid 0.5mg per serving. Marketed internationally for Vitamin B12 deficiency treatment.
• D3 Splash Oral Spray International health supplement containing Vitamin D3 2000 IU per serving. Sold internationally for Vitamin D3 deficiency treatment.
• Cut Down Splash Oral Spray Weight reduction supplement containing Green Coffee Bean Extract, Green Tea Extract, Garcinia Cambogia, and Chromium Picolinate. Marketed internationally.
• Dstress Splash Oral Spray Stress relief supplement containing L-Tryptophan, Valerian Extract, Rosemary extract, Ginkgo biloba, Magnesium oxide, and Theanine. Marketed internationally.
• Antioxidant Granule Composition Patented antioxidant formulation in granule form developed by Zota Healthcare's R&D team.
• Novel Oral Composition for Respiratory Allergic Disease Patented oral formulation for respiratory allergic diseases developed by Zota Healthcare's R&D team.

Quantifiable outcome

• Medicines offered at 30-90% discounts through DavaIndia stores
• +3 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Seven partnerships are on record, tiered core.

• KMHP Ventures LimitedcoreStrategic or Co-development Partner · 22 June 2026Zota Healthcare acquired 20,00,000 equity shares through rights issue for ₹2 Cr to fund KMHP Ventures' launch of 'Ugo Generic' retail stores across India. Subsidiary incorporated January 2026.
• Curexis Ventures Private LimitedcoreStrategic or Co-development Partner · 22 June 2026Zota Healthcare invested ₹2 crore to acquire 10,00,000 equity shares through rights issue. Funds support expansion of SKIA pharmacy stores and working capital requirements.
• Akshay KumarcoreGTM or Marketing Partner · 19 May 2026Akshay Kumar signed as brand ambassador for Zota Healthcare and UGO Generic brand. Supports expansion of generic pharmacy retail network across India.
• MS DhonicoreGTM or Marketing Partner · 25 December 2025MS Dhoni signed as brand ambassador for Zota Healthcare. The partnership aims to enhance brand visibility and credibility for the DavaIndia generic pharmacy chain and overall company image.
• Suniel ShettycoreGTM or Marketing Partner · 25 December 2025Suniel Shetty signed as brand ambassador for Zota Healthcare. The partnership supports the company's retail pharmacy expansion strategy and brand building efforts.
• Kapil DevcoreGTM or Marketing Partner · 24 December 2019Kapil Dev appointed as brand ambassador to enhance brand visibility and credibility for the company.
• Franchisee India Partners Private LimitedcoreChannel Partner/ Reseller/ Distributor · 31 May 2018Agreement signed with Franchisee India Partners for franchise business operations supporting DavaIndia retail pharmacy chain expansion.

Scale indicators16 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• MedPlus Health Services: India's largest branded retail pharmacy chain. MedPlus is the most directly comparable to DavaIndia — both compete for footfall-driven generic prescription volume across India — though MedPlus skews more toward branded generics while DavaIndia leads with a discount-pricing model.
• Apollo Pharmacy: Retail pharmacy arm of Apollo Hospitals, one of India's largest pharmacy chains with thousands of stores. Operates in the same broad category as DavaIndia, although Apollo's pricing strategy emphasizes branded and hospital-linked prescriptions rather than 30-90% generic discounts.
• Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP / Jan Aushadhi): Government of India scheme operating thousands of low-cost generic pharmacy outlets nationwide — the closest direct competitor to DavaIndia on the "affordable generic" value proposition, with state backing that creates formidable pricing pressure.

Broad incumbents

• Sun Pharmaceutical Industries: India's largest pharma manufacturer by revenue. Comparable to Zota on the manufacturing/marketing and patented-formulation fronts (branded generics, specialty formulations, export business across regulated markets), though at vastly greater scale and with no direct retail pharmacy chain.
• Cipla: One of India's top three generic pharma manufacturers with strong respiratory, antiretroviral, and chronic-therapeutic franchises. Comparable to Zota on branded generic manufacturing, R&D depth, and international exports — though with much larger scale and more diversified therapy mix.
• Dr. Reddy's Laboratories: Indian multinational focused on generics, biosimilars, and proprietary products with significant US and emerging-market exposure. Comparable on the export-and-patented-formulation dimensions; Zota's RTFIT/GMFIT strategy mirrors DRL's branded specialty niche within a broad generics portfolio.
• Lupin Limited: Major Indian generic manufacturer with strong chronic-disease franchises (cardiovascular, diabetes, respiratory) — directly comparable to Zota's therapy-area R&D focus and large Indian distributor network.
• Aurobindo Pharma: India's third-largest pharma company by revenue, primarily a generic API and finished-dose manufacturer with a deep regulated-market export footprint. Comparable on the WHO-GMP manufacturing and export-to-22-countries dimensions of Zota's business.

Emerging players

• Tata 1mg: India's leading online pharmacy and healthcare platform. Touches Zota's value proposition (affordable medicines, pan-India reach) but through digital channels rather than brick-and-mortar — a partial competitor rather than a direct store-format rival.
• PharmEasy: Indian online pharmacy aggregator with chronic-disease and discount-driven positioning. Addresses the same "affordable generics to Indian consumers" pain point as DavaIndia but via an app-and-delivery model; increasing convergence with physical pharmacy players could heighten competition for Zota over time.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xtwitter.com/zotahealthcare
• Facebookfacebook.com/ZotaHealthCare
• LinkedInlinkedin.com/company/zota-health-care-limited

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries7 records

Funding overview

Funding rounds1 record

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zota Health Care